Cara Therapeutics Stock (NASDAQ: CARA) stock price, news, charts, stock research, profile.
You can purchase shares of Cara Therapeutics (NASDAQ:CARA) through any online brokerage.
Other companies in Cara Therapeutics’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Bioage Labs (NASDAQ:BIOA), Aquestive Therapeutics (NASDAQ:AQST), Telomir Pharmaceuticals (NASDAQ:TELO) and Trevi Therapeutics (NASDAQ:TRVI).
Cara Therapeutics has a consensus price target of $12.57.
The stock price for Cara Therapeutics (NASDAQ: CARA) is $6.49 last updated December 31, 2024 at 7:01 PM EST.
There are no upcoming dividends for Cara Therapeutics.
Cara Therapeutics’s Q4 earnings are confirmed for Monday, March 3, 2025.
There is no upcoming split for Cara Therapeutics.
Cara Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.